This could be significant. Pharma company Gilead's new drug Remdesivir is showing a lot of promise. Final trial results awaited, but almost all severe-symptom patients recovered in one study.
— Chetan Bhagat (@chetan_bhagat) April 17, 2020
Enough to move global markets up. Gilead's own stock up 16%.https://t.co/WoaS2jsx0n
Friday, April 17, 2020
Dow futures rally after Gilead coronavirus drug reportedly shows effectiveness
